ImageneBio Inc (IMA)
$4.24-0.47%Close
SELLCRISIS · day 2
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $48M
- Beta
- 0.74
- P/E (TTM)
- -0.88
- Short % float
- 0.44%
- Days to cover
- 1.9
- SI change
- -5.0%
- 1W
- -7.83%
- 1M
- -15.37%
- vs SPY 1W
- -8.99%
- vs SPY 1M
- -18.36%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on IMA?
- LOPJLB’s latest quantitative signal on ImageneBio Inc (IMA) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is IMA in?
- ImageneBio Inc (IMA) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does ImageneBio Inc (IMA) do?
- ImageneBio, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for patients with immunological, autoimmune and inflammatory diseases. Its lead product candidate includes IMG-007, a non-depleting anti-OX40 monoclonal antibody that binds to OX40 receptor on activated T cells to block receptor binding to OX40 ligand which is in Phase 1b/2a clinical trial. The company was forme…